Determinants of Residual Viraemia During Combination HIV Treatment: Impacts of Baseline HIV RNA Levels and Treatment Choice

HIV Medicine - United Kingdom
doi 10.1111/hiv.12323
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Combination of CXCL9, CXCL10 and CXCL11 Levels During Primary HIV Infection Predicts HIV Disease Progression

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

RNA Interference Approaches for Treatment of HIV-1 Infection

Genome Medicine
Molecular MedicineGeneticsMolecular Biology
2015English

HIV Prevention in Care and Treatment Settings: Baseline Risk Behaviors Among HIV Patients in Kenya, Namibia, and Tanzania

PLoS ONE
Multidisciplinary
2013English

Factoring in CD4 T Cells During Treatment of HIV

Immunology and Cell Biology
AllergyImmunologyCell Biology
2017English

The Impact of Insurance and HIV Treatment Technology on HIV Testing

2013English

Viral RNA and P24 Antigen as Markers of HIV Disease and Antiretroviral Treatment Success

International Archives of Allergy and Immunology
MedicineAllergyImmunology
2003English

Raltegravir in Combination With Other Antiretroviral Agents for the Treatment of HIV Infection

Infection and Drug Resistance
Infectious DiseasesPharmacology
2010English

Availability of Updated HIV Treatment Guidelines

JAMA - Journal of the American Medical Association
Medicine
1999English

Genotypic Susceptibility Scores and HIV Type 1 RNA Responses in Treatment-Experienced Subjects With HIV Type 1 Infection

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy